HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA

The Lancet

Volumn 326, Issue 8465, 1985, Pages 1150-1154

  Vitols, Sigurd ^a,b,c   Björkholm, Magnus ^a,b,c   Gahrton, Gösta ^a,b,c   Peterson, Curt ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CHEMOTHERAPY; CHOLESTEROL BLOOD LEVEL; DIAGNOSIS; ETIOLOGY; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; FEMALE; HUMAN; LEUKEMIA; LEUKOCYTE COUNT; LIPOPROTEINS, LDL; MALE; MIDDLE AGE; RECEPTORS, LDL; SUPPORT, NON-U.S. GOV'T;

EID: 0022384877     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(85)92679-0     Document Type: Article

References (32)

1. Review of the epidemiological evidence for a possible relationship between hypocholesterolemia and cancer
2. Total serum cholesterol and cancer mortality in a middle-aged male population
3. Plasma lipids and mortality a source of error
4. The cholesterol metabolism in health and anemia
5. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy
6. Studies of serum cholesterol levels in leukemia
7. Serum cholesterol and human cancer
8. Serum lipoprotein levels in patients with cancer
9. The low-density lipoprotein pathway and its relation to atherosclerosis
10. Regulation of plasma cholesterol by lipoprotein receptors
11. Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells
12. Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation
13. Proposals for the classification of the acute leukaemias
14. A study of the reproducibility of the diagnostic criteria for acute leukaemia
15. A simple specific method for precipitation of low density lipoproteins
16. The Stockholm Prospective Study, part 1. The initial values for plasma lipids
17. Hypocholesterolemia as a manifestation of disease activity in chronic myelogenous leukemia
18. Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein
19. Lipids of human leukocytes relation to cell type
20. Cholesterol as a bioregulator in the development and inhibition of leukemia
21. Cholesterol, phospholipids, and fatty acids of normal immature neutrophils comparison with acute myeloblastic leukemia cells and normal neutrophils
22. Effect of cell density and confluency on cholesterol metabolism in cancer cells in monolayer culture
23. Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases
24. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity
25. Hypocholesterolemia in multiple myeloma before and after treatment
26. Serum beta-lipoprotein and other specific protein concentrations in patients with immunocytoma
27. Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecological neoplasms
28. Low-density lipoprotein metabolism in mice with soft tissue tumours
29. In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice
30. Significance of the low density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells
31. Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway
32. Selective uptake of a toxic lipophilic anthracycline derivative by the low-density lipoprotein receptor pathwav in cultured fibroblasts